1. Home
  2. AQST vs SWMR Comparison

AQST vs SWMR Comparison

Compare AQST & SWMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$4.67

Market Cap

529.4M

Sector

Health Care

ML Signal

N/A

Logo Swarmer Inc Common Stock

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$24.03

Market Cap

526.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AQST
SWMR
Founded
2004
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
529.4M
526.1M
IPO Year
2007
2026

Fundamental Metrics

Financial Performance
Metric
AQST
SWMR
Price
$4.67
$24.03
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
2.7M
635.1K
Earning Date
05-01-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,430,000.00
N/A
Revenue This Year
$10.08
$2,862.05
Revenue Next Year
$49.60
$177.93
P/E Ratio
N/A
N/A
Revenue Growth
0.77
N/A
52 Week Low
$2.94
$25.75
52 Week High
$7.55
$83.30

Technical Indicators

Market Signals
Indicator
AQST
SWMR
Relative Strength Index (RSI) 51.60 33.05
Support Level $4.03 N/A
Resistance Level $5.10 $50.08
Average True Range (ATR) 0.23 3.86
MACD -0.08 -0.96
Stochastic Oscillator 23.73 13.66

Price Performance

Historical Comparison
AQST
SWMR

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

Share on Social Networks: